JPRN-UMIN000029015招募中未知
Efficacy of the medical compound of teneligliptin 20 mg and canagliflozin 100 mg with Free Style Libre - Efficacy of the medical compound of teneligliptin and canagliflozin with Free Style Libre
TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology0 个研究点目标入组 40 人开始时间: 2017年9月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients who have renal dysfunction (eGFR is less than 30ml/min/1.73m2) 2. Pregnant women 3. Patients judged by the doctor to be ineligible
研究者
相似试验
已完成
4 期
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30
已完成
3 期
Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT02924064Tanabe Pharma Corporation247
已完成
不适用
Effects of one of antidiabetic agents, teneligliptin, on the vascular endothelium function of ACS patients with diabetesAcute Coronary Syndrome (ACS) and diabetesJPRN-UMIN000018936Saitama Medical Center, Jichi Medical University50
已完成
不适用
The efficacy of teneligliptin in patients with type 2 diabetes mellitusdiabetes mellitusJPRN-UMIN000028763Juntendo University Urayasu Hospital30
已完成
不适用
Effects of Teneligliptin improvement endotherial dysfunction, inflammation, coagulation and oxidative stress in patients with coronary artery disease and diabetes, pilot study(Tiramisu study).Coronary artery diseaseJPRN-UMIN000011960Gunma University30